Videos

AMA leader outlines major threats facing U.S. healthcare: Payment cuts, AI denials, immigration bottlenecks and corporate takeovers
American Medical Association Board Trustee Scott Ferguson, MD, FACR, a diagnostic radiologist, explains the urgent need for Medicare payment reform, concerns about Trump administration public health policy, insurance prior authorization, medical student immigration and the rapid growth of private equity ownership of physicians.
ACR pushes for better explainability of how AI algorithms work
Dana Smetherman, MD, CEO of the American College of Radiology, says the organization wants to see transparent explainability of algorithms to increase public trust.
How anti-DEI healthcare policies are impacting patient care
All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.
AMA deeply concerned about Trump policies and cuts to healthcare spending
American Medical Association President Bruce Scott, MD, has expressed major concerns about significant healthcare spending cuts proposed by the Trump administration. These include reductions to Medicaid, deep cuts to NIH funding, staffing reductions, and policy changes at key federal agencies.
Radiologists call on AMA to push for new federal IT interoperability standards
Dana Smetherman, MD, CEO of the ACR, explains a resolution adopted at the American Medical Association House of Delegates meeting calling for new health IT standards.

Ed Gaines, JD, CCP, vice president of regulatory affairs and industry liaison, Zotec Partners, discusses the No Surprises Act on radiology at the Radiological Society of North America (RSNA) 2022 meeting. Gaines works with RSNA on billing and Medicare issues and spoke in sessions at the RSNA 2022 meeting. Insurance companies have weaponized the No Surprises Act in an effort to cut their costs, he said.

VIDEO: Insurance companies have weaponized the No Surprises Act, may impact patient care

Ed Gaines, JD, CCP, vice president of regulatory affairs and industry liaison, Zotec Partners, discusses the impact of the No Surprises Act on healthcare and medical imaging at the RSNA 2022 meeting

Jorge Soto, MD, chair of the RSNA Annual Meeting Program Planning Committee, chief of radiology, Boston Medical Center, and professor of medicine, Boston University School of Medicine, offers an overview of the trends, hot topics, and innovative research and technology at the Radiological Society of North America (RSNA) 2022 meeting.

VIDEO: Key takeaways from RSNA 2022

Jorge Soto, MD, chair of the RSNA Annual Meeting Program Planning Committee, chief of radiology, Boston Medical Center, offers an overview of the trends, hot topics, research and technology at the Radiological Society of North America (RSNA) 2022 meeting.

Charles E. Kahn, Jr., MD, MS, Editor of the the RSNA journal Radiology: Artificial Intelligence, and professor and vice chair of radiology at the University of Pennsylvania Perelman School of Medicine, discusses trends in radiology medical imaging AI. He has been heavily involved in radiology informatics and has seen up close the evolution of radiology toward deeper integration with AI. #RSNA22

VIDEO: An updated look at the use of AI in radiology

Ahead of RSNA 2022 in Chicago, Charles E. Kahn, Jr., MD, MS, spoke with Radiology Business about how AI is being used by radiologists—and how that may evolve in the years ahead.

Bruce Haffty, MD, president of Radiological Society of North America (RSNA) Board of Directors, chair of radiation oncology, associate vice chancellor for cancer programs at Rutgers Cancer Institute of New Jersey and system director of radiation oncology at RWJBarnabas Health, discusses the president’s address "Diagnostic Imaging: Value From the Lens of the Patient," with Radiology Business. Haffty will present his opening session at RSNA 2022 at 4 p.m., Nov. 27, 2022, in the Arie Crown theater.

VIDEO: RSNA President Bruce Haffty previews the big conference in Chicago

Haffty offered his perspective on the conference as a whole and previewed his presidential address, which is scheduled for early Sunday evening.

Interview with the late-breaking BEST-CLI trial principal investigators Alik Farber from Boston Medical Center, Matthew Menard from Brigham and Women's Hospital, and Ken Rosenfield at Mass General Hospital, at the 2022 American Heart Association (AHA) meeting. The trial looked at endovascular versus bypass surgery in patients with critical limb ischemia (CLI) to see which is better. #AHA22

VIDEO: Surgery vs. endovascular intervention for critical limb ischemia in the BEST-CLI trial

Watch our exclusive interview, recorded live at the AHA Scientific Sessions 2022 conference, with three investigators from the BEST-CLI trial.

Cian McCarthy, MD, cardiovascular fellow, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin. However, he expects that to rise because of high sensitivity troponin (hs-cTn) being included in recent guidelines as a front-line test.

VIDEO: High sensitivity cardiac troponin use based on the NCDR Chest Pain-MI Registry

Cian McCarthy, MD, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin.

VIDEO: Meet the radiologist who’s in the hunt for NFL Fan of the Year

Breast-imaging specialist Amy Patel, MD, has already been named Fan No. 1 by her hometown Kansas City Chiefs. Now she’s up against national championship finalists from the NFL’s 31 other teams.

Jason Andrade, MD, FRCPC, FHRS, director of electrophysiology, Vancouver General Hospital, clinical associate professor, University of British Columbia, and principal investigator for the PROGRESSIVE AF trial, explains how cryoablation can be used as a front-line treatment for atrial fibrillation (AFib). He presented this late-breaking trial at the American Heart Association (AHA) 2022 meeting, which showed the therapy can be used instead of trying drug therapy first. #AHA22 #EPeeps

VIDEO: Cryoablation can be used as frontline therapy before drugs: PROGRESSIVE AF trial

Jason Andrade, MD, director of electrophysiology, Vancouver General Hospital, and principal investigator of the PROGRESSIVE AF trial, explains how cryoablation can be used as a frontline treatment for atrial fibrillation (AFib) before drugs in this AHA late-breaker.

Videos

AMA leader outlines major threats facing U.S. healthcare: Payment cuts, AI denials, immigration bottlenecks and corporate takeovers

ACR pushes for better explainability of how AI algorithms work

How anti-DEI healthcare policies are impacting patient care

AMA deeply concerned about Trump policies and cuts to healthcare spending

Radiologists call on AMA to push for new federal IT interoperability standards